Modulation of Acetylcholine Receptor by Antibody Against the Receptor

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1977 Jul 1

PMID 268657

Citations 56

Authors

S Heinemann

S Bevan

R Kullberg

J Lindstrom

J Rice

Affiliations

Soon will be listed here.

Abstract

Antibody against acetylcholine receptor induces an increase in the rate of degradation of acetylcholine receptors on a mouse cell line (BC(3)H-1) and cultured rat skeletal muscle. The increased rate of degradation results in a lowered density of acetylcholine receptors on muscle membrane and a lowered sensitivity to iontophoretically applied acetylcholine. The modulation of acetylcholine receptor is energy, temperature, and time dependent and may be related to antigenic modulation found in other systems. Acetylcholine noise analysis demonstrates that antibody against acetylcholine receptor reduces the channel mean conductance and mean open time slightly. It is concluded that antibody binds to the acetylcholine receptor, impairs its function, and induces receptor degradation. This results in a lowered density of acetylcholine receptor and a lowered sensitivity to acetylcholine. Patients with myasthenia gravis have antibodies to their acetylcholine receptor in their serum. Antigenic modulation of receptor in the muscle of patients with myasthenia gravis could contribute to the observed decrease in amplitudes of miniature endplate potentials and in muscle acetylcholine sensitivity, and the symptoms of muscular weakness.

Citing Articles

Role of complement in myasthenia gravis.

San P, Jacob S Front Neurol. 2023; 14:1277596.

PMID: 37869140 PMC: 10585143. DOI: 10.3389/fneur.2023.1277596.

A Functional Human-on-a-Chip Autoimmune Disease Model of Myasthenia Gravis for Development of Therapeutics.

Smith V, Nguyen H, Rumsey J, Long C, Shuler M, Hickman J Front Cell Dev Biol. 2021; 9:745897.

PMID: 34881241 PMC: 8645836. DOI: 10.3389/fcell.2021.745897.

Glycine receptor autoantibodies disrupt inhibitory neurotransmission.

Crisp S, Dixon C, Jacobson L, Chabrol E, Irani S, Leite M Brain. 2019; 142(11):3398-3410.

PMID: 31591639 PMC: 6821286. DOI: 10.1093/brain/awz297.

Autoantibodies in Neuropsychiatric Disorders.

Hoffmann C, Zong S, Mane-Damas M, Molenaar P, Losen M, Martinez-Martinez P Antibodies (Basel). 2019; 5(2).

PMID: 31557990 PMC: 6698850. DOI: 10.3390/antib5020009.

Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review.

Chamberlain J, Huda S, Whittam D, Matiello M, Morgan B, Jacob A J Neurol. 2019; 268(5):1643-1664.

PMID: 31482201 DOI: 10.1007/s00415-019-09498-4.

References

ELMQVIST D, HOFMANN W, KUGELBERG J, QUASTEL D . AN ELECTROPHYSIOLOGICAL INVESTIGATION OF NEUROMUSCULAR TRANSMISSION IN MYASTHENIA GRAVIS. J Physiol. 1964; 174:417-34. PMC: 1368938. DOI: 10.1113/jphysiol.1964.sp007495. View

Katz B, Miledi R . THE DEVELOPMENT OF ACETYLCHOLINE SENSITIVITY IN NERVE-FREE SEGMENTS OF SKELETAL MUSCLE. J Physiol. 1964; 170:389-96. PMC: 1368823. DOI: 10.1113/jphysiol.1964.sp007339. View

Devreotes P, Gardner J, Fambrough D . Kinetics of biosynthesis of acetylcholine receptor and subsequent incorporation into plasma membrane of cultured chick skeletal muscle. Cell. 1977; 10(3):365-73. DOI: 10.1016/0092-8674(77)90023-x. View

Patrick J, McMillan J, WOLFSON H, OBrien J . Acetylcholine receptor metabolism in a nonfusing muscle cell line. J Biol Chem. 1977; 252(6):2143-53. View

Merlie J, Changeux J, Gros F . Acetylcholine receptor degradation measured by pulse chase labelling. Nature. 1976; 264(5581):74-6. DOI: 10.1038/264074a0. View

Lindstrom J, Seybold M, Lennon V, Whittingham S, Duane D . Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology. 1976; 26(11):1054-9. DOI: 10.1212/wnl.26.11.1054. View

Katz B, Miledi R . The statistical nature of the acetycholine potential and its molecular components. J Physiol. 1972; 224(3):665-99. PMC: 1331515. DOI: 10.1113/jphysiol.1972.sp009918. View

Anderson C, Stevens C . Voltage clamp analysis of acetylcholine produced end-plate current fluctuations at frog neuromuscular junction. J Physiol. 1973; 235(3):655-91. PMC: 1350786. DOI: 10.1113/jphysiol.1973.sp010410. View

BERANEK R, Vyskocil F . The action of tubocurarine and atropine on the normal and denervated rat diaphragm. J Physiol. 1967; 188(1):53-66. PMC: 1395993. DOI: 10.1113/jphysiol.1967.sp008123. View

10.

Lamm M, Boyse E, Old L, STOCKERT E . Modulation of TL (thymus-leukemia) antigens by Fab-fragments of TL antibody. J Immunol. 1968; 101(1):99-103. View

11.

Berg D, Hall Z . Loss of alpha-bungarotoxin from junctional and extrajunctional acetylcholine receptors in rat diaphragm muscle in vivo and in organ culture. J Physiol. 1975; 252(3):771-89. PMC: 1348494. DOI: 10.1113/jphysiol.1975.sp011169. View

12.

Schubert D, Harris A, Devine C, Heinemann S . Characterization of a unique muscle cell line. J Cell Biol. 1974; 61(2):398-413. PMC: 2109296. DOI: 10.1083/jcb.61.2.398. View

13.

Gavin 3rd J, Roth J, Neville Jr D, De Meyts P, Buell D . Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. Proc Natl Acad Sci U S A. 1974; 71(1):84-8. PMC: 387937. DOI: 10.1073/pnas.71.1.84. View

14.

Lee C, TSENG L, Chiu T . Influence of denervation on localization of neurotoxins from clapid venoms in rat diaphragm. Nature. 1967; 215(5106):1177-8. DOI: 10.1038/2151177a0. View

15.

Kebabian J, Zatz M, Romero J, Axelrod J . Rapid changes in rat pineal beta-adrenergic receptor: alterations in l-(3H)alprenolol binding and adenylate cyclase. Proc Natl Acad Sci U S A. 1975; 72(9):3735-9. PMC: 433072. DOI: 10.1073/pnas.72.9.3735. View

16.

Mukherjee C, Caron M, Lefkowitz R . Catecholamine-induced subsensitivity of adenylate cyclase associated with loss of beta-adrenergic receptor binding sites. Proc Natl Acad Sci U S A. 1975; 72(5):1945-9. PMC: 432665. DOI: 10.1073/pnas.72.5.1945. View

17.

Bender A, Ringel S, Engel W, Daniels M, Vogel Z . Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction. Lancet. 1975; 1(7907):607-9. DOI: 10.1016/s0140-6736(75)91886-3. View

18.

Aharonov A, Abramsky O, Tarrab-Hazdai R, Fuchs S . Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis. Lancet. 1975; 2(7930):340-2. DOI: 10.1016/s0140-6736(75)92779-8. View

19.

Vogel Z, Sytkowski A, Nirenberg M . Acetylcholine receptors of muscle grown in vitro. Proc Natl Acad Sci U S A. 1972; 69(11):3180-4. PMC: 389730. DOI: 10.1073/pnas.69.11.3180. View

20.

Patrick J, Heinemann S, Lindstrom J, Schubert D, Steinbach J . Appearance of acetylcholine receptors during differentiation of a myogenic cell line. Proc Natl Acad Sci U S A. 1972; 69(10):2762-6. PMC: 389639. DOI: 10.1073/pnas.69.10.2762. View